Continuing Medical Education (CME)

Lippincott deepens CE, research connection

Lippincott deepens CE, research connection

By

The publisher says the latest release enriches the CE experience through direct links to Nursing Advisor content.

JAMA taps NEJM's Easley as publisher

JAMA taps NEJM's Easley as publisher

By

The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society's publications, soon to be rolled up into the JAMA brand.

Has commercial support for CME bottomed out?

By

Industry support for continuing medical education (CME) has been waning the last two years, but some say the bottom may be in sight.

ACCME plan for limited transparency draws support

By

Comments to a recent ACCME proposal formed a clear consensus: Accredited med-ed providers who break the rules should not be identified, unless changes in their accreditation status occur.

"Facebook for pharmacists" to offer news, CE and community

"Facebook for pharmacists" to offer news, CE and community

By

JMI Health is launching PharmQD, which aims to be something like a cross between LinkedIn and Facebook for pharmacy students, hospital and retail pharmacists, said JMI SVP, eproducts Tina Pang Mayer (pictured).

Coalition flags ACCME plans

By

The Coalition for Healthcare Communication said it doesn't oppose ACCME's proposal to set up an independent entity for disbursal of CME funding - provided that it's not the only game in town and CME providers don't have to pay for it.

AMA ethics group rethinks CME funding

By

A pair of American Medical Association committee reports urges that industry-funded CME be put on a tighter leash, but they're a far cry from the ban on commercial support called for by the AMA's Council on Ethical and Judicial Affairs a year ago.

WebMD to launch Medscape iPhone app

WebMD to launch Medscape iPhone app

By

WebMD hopes to extend its professional network reach with the launch of a Medscape iPhone application. The app will become available during the last week of May, or in early June, according to a WebMD spokesperson.

IOM: quit gifts, reps, samples

By

Physicians and medical institutions should shun gifts, reps, samples and ghostwriting, said the Institute of Medicine's conflict of interest committee in its full recommendations.

ACCME weighs pharma-free labeling

By

The Accreditation Council for Continuing Medical Education is considering offering an accreditation flagging CME as being free of drug and device industry support -- a kind of Good Housekeeping Seal for CME.

ACCME won't ban industry funding of CME

By

The Accreditation Council for Continuing Medical Education said that for the time being, it won't ban commercial support of CME.

Associations should cut ties with pharma, says JAMA

By

The Journal of the American Medical Association is calling for professional medical associations to sever all ties with the drug industry--with exception to journal advertising and exhibit hall fees, of course.

APA to phase out pharma-sponsored CME, dinners

By

The American Psychiatric Association (APA) will put an end to industry-sponsored continuing medical education (CME) and meals served during its annual meetings, the association said Wednesday.

GSK to expand clinical trial disclosures

GSK to expand clinical trial disclosures

By

GlaxoSmithKline said it will broaden its transparency policies to include greater disclosure of its clinical research and the physicians the company works with on clinical trials.

Iowa Senate passes harsh gifts, data ban bill

Iowa Senate passes harsh gifts, data ban bill

By

Iowa's state Senate passed a healthcare bill containing some of the toughest restrictions on drug company contacts with physicians yet.

Massachusetts antes up with tough transparency law

By

Massachusetts passed regulation governing drug and device company sales and marketing that the state's deputy counsel boasted is "the most stringent of the existing state laws" and "sets PhRMA and AdvaMed codes as the floor."

MedPAC calls for reporting of samples

By

An influential advisory board urged Congress to impose far-reaching transparency rules on payments to healthcare professionals and organizations interacting with the drug industry--including reporting samples, in part to aid counterdetailing efforts.

Medtronic vows public disclosure of payments to docs

Medtronic vows public disclosure of payments to docs

By

Medtronic said it will disclose payments to US physicians starting in 2011.

BIO punts on PhRMA physician interaction code

By

The Biotechnology Industry Organization (BIO) issued a statement calling on member companies to develop their own codes of conduct on interaction with physicians, but again stopped short of adopting the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals.

Pfizer hops on transparency bandwagon with disclosures

Pfizer hops on transparency bandwagon with disclosures

By

Following the lead of peers like Lilly and GSK, Pfizer announced plans to publicly disclose payments to US physicians, healthcare professionals and clinical investigators in excess of $500 per year, along with non-monetary items worth more than $25.

Sunshine bill is back with sharper teeth

Sunshine bill is back with sharper teeth

By

Senators Chuck Grassley (R-IA) and Herb Kohl (D-WI) reintroduced their Physician Payments Sunshine Act, which would require that manufacturers and group purchasing organizations disclose payments to physicians of $100 or more.

Congressional pharma foes square off over committee gig

By

Fight! Fight! Two leading congressional critics of the pharma industry—Rep. Henry Waxman (D-CA) and John Dingell (D-MI)—are at odds over a committee chairmanship.

Effort seeks to educate faculty on promotional vs. certified CME

By

A new training effort aims to help medical education faculty distinguish between certified and promotional CME.

Lilly settlement with states demands even greater transparency

Lilly settlement with states demands even greater transparency

By

Eli Lilly & Co.'s $62 million settlement with 32 states and the District of Columbia over off-label Zyprexa marketing comes with an agreement requiring, among other things, that the company furnish those state AGs with a list of all healthcare professionals paid more than $100 for promotional speaking and consulting in the US.

Minnesota med school weighing gift and grants ban

By

The University of Minnesota Medical School is weighing a tough ban on gifts to physicians and requiring docs to publicly disclose all relationships with drug companies, according to a University newspaper.

Wanted: smarter reps, says survey

By

A snap survey of physicians found a yearning for smarter sales reps who know their disease states back and forth and can use clinical studies in their details.

Lilly to post registry of physician payments

Lilly to post registry of physician payments

By

Lilly announced plans to broaden its transparency efforts to include publicly disclosing payments to US physicians as well as grants.

Customized journal offers à la carte content

Customized journal offers à la carte content

By

Sequence Medical is launching what it claims to be the first-ever individually customizable medical journal in the US.

ACCME proposals imperil CME, critics say

By

As ACCME's public comment period on a proposed restructuring of the CME funding structure drew to a close, industry groups blasted the accrediting body for what they see as an overreaction imperiling medical education.

ACCME data show commercial support for CME flat in 2007

By

Total commercial support of accredited CME scarcely budged in 2007, rising 1% to $1.2 billion, while the share of commercial support going to publishing and education companies declined 4.2% to $594 million, according to the ACCME's annual report.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.